Capital Fund Management S.A. Crispr Therapeutics Ag Transaction History

Capital Fund Management S.A.

$33.7 Billion
Q2 2024

A detailed history of Capital Fund Management S.A. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Capital Fund Management S.A. holds 85,400 shares of CRSP stock, worth $4.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

85,400

Previous 56,114 52.19%

Holding current value

$4.23 Million

Previous $3.82 Million 20.61%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $1.03 Million - $1.51 Million	-16,905 Reduced 23.15%	56,114 $3.82 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $2.82 Million - $5.27 Million	73,019 New	73,019 $4.57 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $1.29 Million - $2.02 Million	29,785 Added 243.32%	42,026 $2.36 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $1.97 Million - $2.69 Million	-48,013 Reduced 79.68%	12,241 $553,000
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $2.36 Million - $3.96 Million	60,254 New	60,254 $2.45 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $4.96 Million - $8.47 Million	-114,730 Reduced 52.42%	104,142 $6.33 Million
Q1 2022 May 12, 2022	BUY	$53.19 - $79.24 $6.91 Million - $10.3 Million	129,831 Added 145.81%	218,872 $13.7 Million
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $2.59 Million - $4.11 Million	-36,926 Reduced 29.31%	89,041 $6.75 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $12.3 Million - $17.5 Million	111,461 Added 768.38%	125,967 $14.1 Million
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $645,073 - $1.04 Million	-6,397 Reduced 30.6%	14,506 $2.35 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $2.31 Million - $4.39 Million	20,903 New	20,903 $2.55 Million
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $865,056 - $1.88 Million	-10,858 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $300,105 - $384,746	3,823 Added 54.34%	10,858 $908,000
Q1 2020 May 13, 2020	BUY	$33.68 - $62.53 $120,069 - $222,919	3,565 Added 102.74%	7,035 $298,000
Q4 2019 Feb 13, 2020	SELL	$36.68 - $73.13 $1.12 Million - $2.24 Million	-30,570 Reduced 89.81%	3,470 $211,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $1.51 Million - $2.24 Million	34,040 New	34,040 $1.51 Million

Others Institutions Holding CRSP

# of Institutions

523

Shares Held

58M

Call Options Held

1.73M

Put Options Held

1.84M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Crispr Therapeutics Ag Transaction History